The mechanism of peptide exchange by mhc II molecules
Yüklə 5,04 Kb. Pdf görüntüsü
|
85 References Call, M.J., Xing, X., Cuny, G.D., Seth, N.P., Altmann, D.M., Fugger, L., Krogsgaard, M., Stein, R.L., and Wucherpfennig, K.W. (2009). In vivo enhancement of peptide display by MHC class II molecules with small molecule catalysts of peptide exchange. J Immunol 182, 6342-6352. Chen, V.B., Arendall, W.B., 3rd, Headd, J.J., Keedy, D.A., Immormino, R.M., Kapral, G.J., Murray, L.W., Richardson, J.S., and Richardson, D.C. (2010). MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr 66, 12-21. Chen, X., Laur, O., Kambayashi, T., Li, S., Bray, R.A., Weber, D.A., Karlsson, L., and Jensen, P.E. (2002). Regulated expression of human histocompatibility leukocyte antigen (HLA)-DO during antigen-dependent and antigen-independent phases of B cell development. J Exp Med 195, 1053-1062. Cho, S.G., Attaya, M., and Monaco, J.J. (1991). New class II-like genes in the murine MHC. Nature 353, 573-576. Chou, C.L., and Sadegh-Nasseri, S. (2000). HLA-DM recognizes the flexible conformation of major histocompatibility complex class II. J Exp Med 192, 1697-1706. Cresswell, P. (1996). Invariant chain structure and MHC class II function. Cell 84, 505-507. Day, C.L., Seth, N.P., Lucas, M., Appel, H., Gauthier, L., Lauer, G.M., Robbins, G.K., Szczepiorkowski, Z.M., Casson, D.R., Chung, R.T., et al. (2003). Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers. J Clin Invest 112, 831-842. De Wall, S.L., Painter, C., Stone, J.D., Bandaranayake, R., Wiley, D.C., Mitchison, T.J., Stern, L.J., and DeDecker, B.S. (2006). Noble metals strip peptides from class II MHC proteins. Nat Chem Biol 2, 197-201. Delaglio, F., Grzesiek, S., Vuister, G.W., Zhu, G., Pfeifer, J., and Bax, A. (1995). NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 6, 277-293. Denzin, L.K., and Cresswell, P. (1995). HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. Cell 82, 155-165. Denzin, L.K., Sant'Angelo, D.B., Hammond, C., Surman, M.J., and Cresswell, P. (1997). Negative regulation by HLA-DO of MHC class II-restricted antigen processing. Science 278, 106-109. Deshaies, F., Brunet, A., Diallo, D.A., Denzin, L.K., Samaan, A., and Thibodeau, J. (2005). A point mutation in the groove of HLA-DO allows egress from the endoplasmic reticulum independent of HLA-DM. Proc Natl Acad Sci U S A 102, 6443-6448. Deussing, J., Roth, W., Saftig, P., Peters, C., Ploegh, H.L., and Villadangos, J.A. (1998). Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation. Proc Natl Acad Sci U S A 95, 4516-4521. Doebele, R.C., Busch, R., Scott, H.M., Pashine, A., and Mellins, E.D. (2000). Determination of the HLA-DM interaction site on HLA-DR molecules. Immunity 13, 517-527. Emsley, P., and Cowtan, K. (2004). Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60, 2126-2132. 86 References Falk, K., Lau, J.M., Santambrogio, L., Esteban, V.M., Puentes, F., Rotzschke, O., and Strominger, J.L. (2002). Ligand exchange of major histocompatibility complex class II proteins is triggered by H-bond donor groups of small molecules. J Biol Chem 277, 2709-2715. Ferrante, A., and Gorski, J. (2010). Cutting edge: HLA-DM-mediated peptide exchange functions normally on MHC class II-peptide complexes that have been weakened by elimination of a conserved hydrogen bond. J Immunol 184, 1153-1158. Germain, R.N. (1994). MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76, 287-299. Germain, R.N., and Rinker, A.G., Jr. (1993). Peptide binding inhibits protein aggregation of invariant-chain free class II dimers and promotes surface expression of occupied molecules. Nature 363, 725-728. Goronzy, J.J., and Weyand, C.M. (2005). Rheumatoid arthritis. Immunol Rev 204, 55-73. Gunther, S., Schlundt, A., Sticht, J., Roske, Y., Heinemann, U., Wiesmuller, K.H., Jung, G., Falk, K., Rotzschke, O., and Freund, C. (2010). Bidirectional binding of invariant chain peptides to an MHC class II molecule. Proc Natl Acad Sci U S A 107, 22219-22224. Gupta, S., Hopner, S., Rupp, B., Gunther, S., Dickhaut, K., Agarwal, N., Cardoso, M.C., Kuhne, R., Wiesmuller, K.H., Jung, G., et al. (2008). Anchor side chains of short peptide fragments trigger ligand-exchange of class II MHC molecules. PLoS One 3, e1814. Hauptmann, G., and Bahram, S. (2004). Genetics of the central MHC. Curr Opin Immunol 16, 668-672. Hopner, S., Dickhaut, K., Hofstatter, M., Kramer, H., Ruckerl, D., Soderhall, J.A., Gupta, S., Marin-Esteban, V., Kuhne, R., Freund, C., et al. (2006). Small organic compounds enhance antigen loading of class II major histocompatibility complex proteins by targeting the polymorphic P1 pocket. J Biol Chem 281, 38535-38542. Hornell, T.M., Burster, T., Jahnsen, F.L., Pashine, A., Ochoa, M.T., Harding, J.J., Macaubas, C., Lee, A.W., Modlin, R.L., and Mellins, E.D. (2006). Human dendritic cell expression of HLA-DO is subset specific and regulated by maturation. J Immunol 176, 3536-3547. Inoko, H., Ando, A., Kimura, M., and Tsuji, K. (1985). Isolation and characterization of the cDNA clone and genomic clones of a new HLA class II antigen heavy chain, DO alpha. J Immunol 135, 2156-2159. Jones, T.A., Zou, J.Y., Cowan, S.W., and Kjeldgaard, M. (1991). Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A 47 ( Pt 2), 110-119. Jonsson, A.K., and Rask, L. (1989). Human class II DNA and DOB genes display low sequence variability. Immunogenetics 29, 411-413. Kalandadze, A., Galleno, M., Foncerrada, L., Strominger, J.L., and Wucherpfennig, K.W. (1996). Expression of recombinant HLA-DR2 molecules. Replacement of the hydrophobic transmembrane region by a leucine zipper dimerization motif allows the assembly and secretion of soluble DR alpha beta heterodimers. J Biol Chem 271, 20156-20162. Keller, R.L.J. (2004). The computer aided resonance assignment tutorial. Cantina Verlag, Goldau, Switzerland. 87 References Kelly, A.P., Monaco, J.J., Cho, S.G., and Trowsdale, J. (1991). A new human HLA class II- related locus, DM. Nature 353, 571-573. Kleid, D.G., Yansura, D., Small, B., Dowbenko, D., Moore, D.M., Grubman, M.J., McKercher, P.D., Morgan, D.O., Robertson, B.H., and Bachrach, H.L. (1981). Cloned viral protein vaccine for foot-and-mouth disease: responses in cattle and swine. Science 214, 1125-1129. Kropshofer, H., Vogt, A.B., Moldenhauer, G., Hammer, J., Blum, J.S., and Hammerling, G.J. (1996). Editing of the HLA-DR-peptide repertoire by HLA-DM. Embo J 15, 6144-6154. Kropshofer, H., Vogt, A.B., Thery, C., Armandola, E.A., Li, B.C., Moldenhauer, G., Amigorena, S., and Hammerling, G.J. (1998). A role for HLA-DO as a co-chaperone of HLA- DM in peptide loading of MHC class II molecules. EMBO J 17, 2971-2981. Lamb, C.A., and Cresswell, P. (1992). Assembly and transport properties of invariant chain trimers and HLA-DR-invariant chain complexes. J Immunol 148, 3478-3482. Lanzavecchia, A., Reid, P.A., and Watts, C. (1992). Irreversible association of peptides with class II MHC molecules in living cells. Nature 357, 249-252. Leddon, S.A., and Sant, A.J. (2010). Generation of MHC class II-peptide ligands for CD4 T-cell allorecognition of MHC class II molecules. Curr Opin Organ Transplant 15, 505-511. Liljedahl, M., Kuwana, T., Fung-Leung, W.P., Jackson, M.R., Peterson, P.A., and Karlsson, L. (1996). HLA-DO is a lysosomal resident which requires association with HLA-DM for efficient intracellular transport. EMBO J 15, 4817-4824. Liljedahl, M., Winqvist, O., Surh, C.D., Wong, P., Ngo, K., Teyton, L., Peterson, P.A., Brunmark, A., Rudensky, A.Y., Fung-Leung, W.P., and Karlsson, L. (1998). Altered antigen presentation in mice lacking H2-O. Immunity 8, 233-243. Lindstedt, R., Liljedahl, M., Peleraux, A., Peterson, P.A., and Karlsson, L. (1995). The MHC class II molecule H2-M is targeted to an endosomal compartment by a tyrosine-based targeting motif. Immunity 3, 561-572. Marin-Esteban, V., Falk, K., and Rotzschke, O. (2003). Small-molecular compounds enhance the loading of APC with encephalitogenic MBP protein. J Autoimmun 20, 63-69. Marin-Esteban, V., Falk, K., and Rotzschke, O. (2004). "Chemical analogues" of HLA-DM can induce a peptide-receptive state in HLA-DR molecules. J Biol Chem 279, 50684-50690. Marks, M.S., Roche, P.A., van Donselaar, E., Woodruff, L., Peters, P.J., and Bonifacino, J.S. (1995). A lysosomal targeting signal in the cytoplasmic tail of the beta chain directs HLA-DM to MHC class II compartments. J Cell Biol 131, 351-369. McCoy, A.J., Grosse-Kunstleve, R.W., Adams, P.D., Winn, M.D., Storoni, L.C., and Read, R.J. (2007). Phaser crystallographic software. J Appl Crystallogr 40, 658-674. Mehra, N.K., and Kaur, G. (2003). MHC-based vaccination approaches: progress and perspectives. Expert Rev Mol Med 5, 1-17. Miozzari, G.F., and Yanofsky, C. (1978). Translation of the leader region of the Escherichia coli tryptophan operon. J Bacteriol 133, 1457-1466. 88 References Morris, P., Shaman, J., Attaya, M., Amaya, M., Goodman, S., Bergman, C., Monaco, J.J., and Mellins, E. (1994). An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules. Nature 368, 551-554. Mosyak, L., Zaller, D.M., and Wiley, D.C. (1998). The structure of HLA-DM, the peptide exchange catalyst that loads antigen onto class II MHC molecules during antigen presentation. Immunity 9, 377-383. Nagarajan, U.M., Lochamy, J., Chen, X., Beresford, G.W., Nilsen, R., Jensen, P.E., and Boss, J.M. (2002). Class II transactivator is required for maximal expression of HLA-DOB in B cells. J Immunol 168, 1780-1786. Nakagawa, T., Roth, W., Wong, P., Nelson, A., Farr, A., Deussing, J., Villadangos, J.A., Ploegh, H., Peters, C., and Rudensky, A.Y. (1998). Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. Science 280, 450-453. Narayan, K., Chou, C.L., Kim, A., Hartman, I.Z., Dalai, S., Khoruzhenko, S., and Sadegh- Nasseri, S. (2007). HLA-DM targets the hydrogen bond between the histidine at position beta81 and peptide to dissociate HLA-DR-peptide complexes. Nat Immunol 8, 92-100. Naruse, T.K., Kawata, H., Anzai, T., Takashige, N., Kagiya, M., Nose, Y., Nabeya, N., Isshiki, G., Tatsumi, N., and Inoko, H. (1999). Limited polymorphism in the HLA-DOA gene. Tissue Antigens 53, 359-365. Naruse, T.K., Kawata, H., Inoko, H., Isshiki, G., Yamano, K., Hino, M., and Tatsumi, N. (2002). The HLA-DOB gene displays limited polymorphism with only one amino acid substitution. Tissue Antigens 59, 512-519. Newcomb, J.R., and Cresswell, P. (1993). Structural analysis of proteolytic products of MHC class II-invariant chain complexes generated in vivo. J Immunol 151, 4153-4163. Nicholson, M.J., Moradi, B., Seth, N.P., Xing, X., Cuny, G.D., Stein, R.L., and Wucherpfennig, K.W. (2006). Small molecules that enhance the catalytic efficiency of HLA-DM. J Immunol 176, 4208-4220. Otwinowski, Z., and Minor, W. (1997). Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol 276, 307-326. Painter, C.A., Cruz, A., Lopez, G.E., Stern, L.J., and Zavala-Ruiz, Z. (2008). Model for the peptide-free conformation of class II MHC proteins. PLoS One 3, e2403. Painter, C.A., Negroni, M.P., Kellersberger, K.A., Zavala-Ruiz, Z., Evans, J.E., and Stern, L.J. (2011). Conformational lability in the class II MHC 310 helix and adjacent extended strand dictate HLA-DM susceptibility and peptide exchange. Proc Natl Acad Sci U S A 108, 19329- 19334. Pashine, A., Busch, R., Belmares, M.P., Munning, J.N., Doebele, R.C., Buckingham, M., Nolan, G.P., and Mellins, E.D. (2003). Interaction of HLA-DR with an acidic face of HLA-DM disrupts sequence-dependent interactions with peptides. Immunity 19, 183-192. Peaper, D.R., Wearsch, P.A., and Cresswell, P. (2005). Tapasin and ERp57 form a stable disulfide-linked dimer within the MHC class I peptide-loading complex. EMBO J 24, 3613- 3623. 89 References Pervushin, K., Riek, R., Wider, G., and Wuthrich, K. (1997). Attenuated T2 relaxation by mutual cancellation of dipole-dipole coupling and chemical shift anisotropy indicates an avenue to NMR structures of very large biological macromolecules in solution. Proc Natl Acad Sci U S A 94, 12366-12371. Rabinowitz, J.D., Vrljic, M., Kasson, P.M., Liang, M.N., Busch, R., Boniface, J.J., Davis, M.M., and McConnell, H.M. (1998). Formation of a highly peptide-receptive state of class II MHC. Immunity 9, 699-709. Reay, P.A., Wettstein, D.A., and Davis, M.M. (1992). pH dependence and exchange of high and low responder peptides binding to a class II MHC molecule. EMBO J 11, 2829-2839. Reith, W., and Mach, B. (2001). The bare lymphocyte syndrome and the regulation of MHC expression. Annu Rev Immunol 19, 331-373. Riese, R.J., Wolf, P.R., Bromme, D., Natkin, L.R., Villadangos, J.A., Ploegh, H.L., and Chapman, H.A. (1996). Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity 4, 357-366. Roche, P.A., Marks, M.S., and Cresswell, P. (1991). Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain. Nature 354, 392-394. Runnels, H.A., Weber, D.A., Moore, J.C., Westerman, L.E., and Jensen, P.E. (1997). Intact proteins can bind to class II histocompatibility molecules with high affinity. Mol Immunol 34, 471-480. Rupp, B., Gunther, S., Makhmoor, T., Schlundt, A., Dickhaut, K., Gupta, S., Choudhary, I., Wiesmuller, K.H., Jung, G., Freund, C., et al. (2011). Characterization of structural features controlling the receptiveness of empty class II MHC molecules. PLoS One 6, e18662. Sadasivan, B., Lehner, P.J., Ortmann, B., Spies, T., and Cresswell, P. (1996). Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity 5, 103-114. Sadegh-Nasseri, S., Chen, M., Narayan, K., and Bouvier, M. (2008). The convergent roles of tapasin and HLA-DM in antigen presentation. Trends Immunol 29, 141-147. Sakaguchi, S. (2010). Immunology: Conditional stability of T cells. Nature 468, 41-42. Sato, A.K., Zarutskie, J.A., Rushe, M.M., Lomakin, A., Natarajan, S.K., Sadegh-Nasseri, S., Benedek, G.B., and Stern, L.J. (2000). Determinants of the peptide-induced conformational change in the human class II major histocompatibility complex protein HLA-DR1. J Biol Chem 275, 2165-2173. Schrodinger, LLC (2010). The PyMOL Molecular Graphics System, Version 1.3r1. Schulze, M.S., and Wucherpfennig, K.W. (2012). The mechanism of HLA-DM induced peptide exchange in the MHC class II antigen presentation pathway. Curr Opin Immunol 24, 105-111. Schuttelkopf, A.W., and van Aalten, D.M. (2004). PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr D Biol Crystallogr 60, 1355- 1363. 90 References Servenius, B., Rask, L., and Peterson, P.A. (1987). Class II genes of the human major histocompatibility complex. The DO beta gene is a divergent member of the class II beta gene family. J Biol Chem 262, 8759-8766. Sloan, V.S., Cameron, P., Porter, G., Gammon, M., Amaya, M., Mellins, E., and Zaller, D.M. (1995). Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 375, 802- 806. Smith, K.J., Pyrdol, J., Gauthier, L., Wiley, D.C., and Wucherpfennig, K.W. (1998). Crystal structure of HLA-DR2 (DRA*0101, DRB1*1501) complexed with a peptide from human myelin basic protein. J Exp Med 188, 1511-1520. Staley, J.P., and Kim, P.S. (1994). Formation of a native-like subdomain in a partially folded intermediate of bovine pancreatic trypsin inhibitor. Protein Sci 3, 1822-1832. Stern, L.J., Brown, J.H., Jardetzky, T.S., Gorga, J.C., Urban, R.G., Strominger, J.L., and Wiley, D.C. (1994). Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368, 215-221. Stratikos, E., Mosyak, L., Zaller, D.M., and Wiley, D.C. (2002). Identification of the lateral interaction surfaces of human histocompatibility leukocyte antigen (HLA)-DM with HLA-DR1 by formation of tethered complexes that present enhanced HLA-DM catalysis. J Exp Med 196, 173-183. Stratikos, E., Wiley, D.C., and Stern, L.J. (2004). Enhanced catalytic action of HLA-DM on the exchange of peptides lacking backbone hydrogen bonds between their N-terminal region and the MHC class II alpha-chain. J Immunol 172, 1109-1117. Studier, F.W., Rosenberg, A.H., Dunn, J.J., and Dubendorff, J.W. (1990). Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol 185, 60-89. Svejgaard, A. (2008). The immunogenetics of multiple sclerosis. Immunogenetics 60, 275-286. Tonnelle, C., DeMars, R., and Long, E.O. (1985). DO beta: a new beta chain gene in HLA-D with a distinct regulation of expression. EMBO J 4, 2839-2847. Trowsdale, J., and Kelly, A. (1985). The human HLA class II alpha chain gene DZ alpha is distinct from genes in the DP, DQ and DR subregions. EMBO J 4, 2231-2237. Vagin, A., and Teplyakov, A. (2010). Molecular replacement with MOLREP. Acta Crystallogr D Biol Crystallogr 66, 22-25. van Ham, M., van Lith, M., Lillemeier, B., Tjin, E., Gruneberg, U., Rahman, D., Pastoors, L., van Meijgaarden, K., Roucard, C., Trowsdale, J., et al. (2000). Modulation of the major histocompatibility complex class II-associated peptide repertoire by human histocompatibility leukocyte antigen (HLA)-DO. J Exp Med 191, 1127-1136. van Ham, S.M., Tjin, E.P., Lillemeier, B.F., Gruneberg, U., van Meijgaarden, K.E., Pastoors, L., Verwoerd, D., Tulp, A., Canas, B., Rahman, D., et al. (1997). HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading. Curr Biol 7, 950-957. van Lith, M., van Ham, M., and Neefjes, J. (2002). Novel polymorphisms in HLA-DOA and HLA-DOB in B-cell malignancies. Immunogenetics 54, 591-595. 91 References Vinuesa, C.G., Tangye, S.G., Moser, B., and Mackay, C.R. (2005). Follicular B helper T cells in antibody responses and autoimmunity. Nat Rev Immunol 5, 853-865. Vogt, A.B., Kropshofer, H., Kalbacher, H., Kalbus, M., Rammensee, H.G., Coligan, J.E., and Martin, R. (1994). Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides. J Immunol 153, 1665-1673. Wearsch, P.A., and Cresswell, P. (2007). Selective loading of high-affinity peptides onto major histocompatibility complex class I molecules by the tapasin-ERp57 heterodimer. Nat Immunol 8, 873-881. Wearsch, P.A., and Cresswell, P. (2008). The quality control of MHC class I peptide loading. Curr Opin Cell Biol 20, 624-631. Weber, D.A., Evavold, B.D., and Jensen, P.E. (1996). Enhanced dissociation of HLA-DR- bound peptides in the presence of HLA-DM. Science 274, 618-620. Zarutskie, J.A., Sato, A.K., Rushe, M.M., Chan, I.C., Lomakin, A., Benedek, G.B., and Stern, L.J. (1999). A conformational change in the human major histocompatibility complex protein HLA-DR1 induced by peptide binding. Biochemistry 38, 5878-5887. Zhou, Z., Callaway, K.A., Weber, D.A., and Jensen, P.E. (2009). Cutting edge: HLA-DM functions through a mechanism that does not require specific conserved hydrogen bonds in class II MHC-peptide complexes. J Immunol 183, 4187-4191. Yüklə 5,04 Kb. Dostları ilə paylaş:
|